D
David R. Rubinow
Researcher at University of North Carolina at Chapel Hill
Publications - 375
Citations - 25515
David R. Rubinow is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Mood & Premenstrual dysphoric disorder. The author has an hindex of 82, co-authored 364 publications receiving 23457 citations. Previous affiliations of David R. Rubinow include National Institutes of Health & George Washington University.
Papers
More filters
Journal Article
Neurohypophyseal function in affective illness
Phillip W. Gold,Robertson Gl,Ballenger Jc,Frederick K. Goodwin,David R. Rubinow,Charles H. Kellner,Post Rm +6 more
Journal ArticleDOI
Menstrually Related Disorders: points of consensus, debate, and disagreement.
Uriel Halbreich,John Bancroft,Lorrain Dennerstein,Jean Endicott,Fobio Faccinetti,Andrea Genazzani,Carol Morse,Barbara L. Parry,David R. Rubinow,Robert Reid,Isaac Schiff,Samuel Smith,Torbjörn Bäckström +12 more
TL;DR: Despite the uncertainty concerning the etiology of MRDs, reasonably efficient treatment modalities do exist, and most sufferers should expect an eventual alleviation of their symptoms if they are treated in a specialized, established, and up-to-date program.
Journal ArticleDOI
A curriculum for teaching psychiatric research bioethics.
TL;DR: A model curriculum and comprehensive background reading list for training in psychiatric research bioethics is described, designed as an interactive seminar in a research fellowship program but can be adapted and incorporated into existing medical school and psychiatry residency training curricula.
Journal Article
Sex-dependent modulation of treatment response.
David R. Rubinow,Molly Moore +1 more
TL;DR: Consideration by the practitioner of sex as a possible contributing factor to treatment nonresponse will enhance the efficacy and precision of clinical interventions.
Journal ArticleDOI
Low CSF somatostatin associated with response to nimodipine in patents with affective illness
Mark A. Frye,Peggy J. Pazzaglia,Mark S. George,David A. Luckenbaugh,Elizabeth Vanderham,Candace L. Davis,David R. Rubinow,Robert M. Post +7 more
TL;DR: Low baseline CSF somatostatin in depression may be associated with response to nimmodipine, which in turn may be related to the ability of nimodipine to increaseCSF som atostatin.